Summary: Dr. Maria Roberta Cilio of UCSF conducted the clinical trial that included Sam and led to FDA approval of Epidiolex. Sam, with his life back after using cannabidiol, watches a show on his phone at his home. Sam Vogelstein, 17, plays with Maisy at his home in Berkeley. He was the first person to use cannabidiol to control epilepsy. The Berkeley boy had his first epileptic seizure when he was 4, and after that, they kept coming, up to 100 a day.
